Addex Therapeutics (ADXN) Research & Development (2022 - 2025)
Historic Research & Development for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$285419.5.
- Addex Therapeutics' Research & Development fell 2091.4% to -$285419.5 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 2982.84%. This contributed to the annual value of $971089.9 for FY2024, which is 2650.58% down from last year.
- Per Addex Therapeutics' latest filing, its Research & Development stood at -$285419.5 for Q3 2025, which was down 2091.4% from -$283194.7 recorded in Q2 2025.
- In the past 5 years, Addex Therapeutics' Research & Development registered a high of $21.3 million during Q4 2022, and its lowest value of -$6.0 million during Q2 2022.
- Over the past 4 years, Addex Therapeutics' median Research & Development value was -$283194.7 (recorded in 2025), while the average stood at $665837.6.
- Data for Addex Therapeutics' Research & Development shows a peak YoY increase of 9456.55% (in 2023) and a maximum YoY decrease of 8822.8% (in 2023) over the last 5 years.
- Addex Therapeutics' Research & Development (Quarter) stood at $21.3 million in 2022, then tumbled by 88.23% to $2.5 million in 2023, then dropped by 25.19% to $1.9 million in 2024, then plummeted by 115.22% to -$285419.5 in 2025.
- Its last three reported values are -$285419.5 in Q3 2025, -$283194.7 for Q2 2025, and -$173584.5 during Q1 2025.